Advertisement

Topics

Barrier Therapeutics Company Profile

16:30 EDT 20th June 2018 | BioPortfolio

BARRIER THERAPEUTICS is a pharmaceutical company focused on the discovery, development and commercialization of pharmaceutical products in the field of dermatology. Our goal is to develop a portfolio of innovative products that address major medical needs in the treatment of dermatological diseases and disorders. Our product pipeline includes marketed products and as well as product candidates in various stages of clinical development.

Location

600 College Road East, Suite 3200
Princeton
08540-6697
United States of America

Contact

Phone: (609) 945-1200
Fax: (609) 945-1212


News Articles [991 Associated News Articles listed on BioPortfolio]

Duke-NUS commercializes discovery to deliver therapeutics across blood brain barrier

(Duke-NUS Medical School) Intellectual property (IP) derived from discoveries made at Duke-NUS Medical School (Duke-NUS) have been licensed to a newly formed biotech start-up, Travecta Therapeutics Pt...

Issues with treating brain cancers through the blood-brain barrier

Dr Phoenix talks to ecancer at the Cancer Research UK Brain Tumour Conference 2018 in London about the blood-brain barrier and the challenges faced when treating brain tumours. He goes on to discuss ...

The xB3 platform efficiently delivers antibodies across the BBB at therapeutic doses

(SAGE) Bioasis Technologies Inc, a biopharmaceutical company developing its xB3 TM proprietary platform technology for the delivery of therapeutics across the blood-brain barrier (BBB) and the treatme...

A blueprint for future blood-nerve barrier and peripheral nerve disease research

(University of Alabama at Birmingham) Researchers have detailed, for the first time, the normal human transcriptome of the blood-nerve barrier. This barrier -- a tight covering of endothelial cells --...

Global Warming Is Transforming the Great Barrier Reef

A new study published online Apr. 18 in Nature shows that corals on the northern Great Barrier Reef experienced a catastrophic die-off following the extended marine heatwave of 2016

First hybrid nanotech device mimicking blood-brain barrier

(Istituto Italiano di Tecnologia - IIT) Researchers at IIT-Istituto Italiano di Tecnologia fabricated an artificial device reproducing a 1:1 scale model of the blood-brain barrier (BBB), the anatomica...

White House locked down after vehicle strikes barrier

WASHINGTON (AP) — The White House was on lockdown for about an hour Friday after a passenger vehicle struck a security barrier. Local media reported that the driver was armed.

Plastic Barrier Laminate TubesEMEA Market Status and Trend Report 20132023 [Report Updated: 12022018] Prices from USD $3480

Report SummaryPlastic Barrier Laminate TubesEMEA Market Status and Trend Report 20132023 offers a comprehensive analysis on Plastic Barrier Laminate Tubes industry, standing on the readers' perspectiv...

PubMed Articles [952 Associated PubMed Articles listed on BioPortfolio]

Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system.

Within the field of RNA therapeutics, antisense oligonucleotide-based therapeutics are a potentially powerful means of treating intractable diseases. However, if these therapeutics are used for the tr...

The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.

Biological barriers are essential for the maintenance of homeostasis in health and disease. Breakdown of the intestinal barrier is an essential aspect of the pathophysiology of gastrointestinal inflam...

Breaking the Barrier - Potent Anti-Inflammatory Activity following Efficient Topical Delivery of Etanercept using Thermoresponsive Nanogels.

Topical administration permits targeted, sustained delivery of therapeutics to human skin. Delivery to the skin, however, is typically limited to lipophilic molecules with molecular weight of < 500 Da...

A Three-Dimensional Arrayed Microfluidic Blood-Brain Barrier Model With Integrated Electrical Sensor Array.

The blood-brain barrier (BBB) poses a unique challenge to the development of therapeutics against neurological disorders due to its impermeabi-lity to most of the chemical compounds. Most in vitro BBB...

In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases.

In situ-based gel drug delivery systems that can bypass the blood-brain barrier, deliver the therapeutics to the desired site, reduce peripheral toxicity and control drug release kinetics have been de...

Clinical Trials [529 Associated Clinical Trials listed on BioPortfolio]

Effect of Intraorifice Barrier on Healing of Apical Periodontitis

Based on various in-vitro studies intraorifice barrier has been suggested as an effective mean to provide seal against coronal microleakage. This study intends to clinically investigate ef...

DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery

To evaluate the safety and effectiveness of DuraGen Plus® Adhesion Barrier Matrix as an adhesion barrier in spinal surgery to reduce the extent of peridural fibrosis formation and radicul...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

VANOS Cream and Skin Barrier Function

The purpose of this study is to determine the effect of short-term therapy using "VANOS Cream," a super-potent topical steroid cream on skin barrier function in patients with atopic dermat...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Companies [1311 Associated Companies listed on BioPortfolio]

Barrier Therapeutics

BARRIER THERAPEUTICS is a pharmaceutical company focused on the discovery, development and commercialization of pharmaceutical products in the field of dermatology. Our goal is to develop a portfolio ...

Barrier Advisors Inc.

A nationally recognized financial and operational advisory firm with offices in Dallas, Texas and Stamford, Conn., Barrier Advisors provides special situations investment banking,...

Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC

Barrier Animal Healthcare

For far too long the control of Ragwort has been haphazard, unreliable and costly, that is until now. Barrier H is an innovation in Ragwort control, destroying this deadly weed in record time, right t...

biOasis Technologies, Inc.

biOasis Technologies Inc. is a biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB). The delivery of t...

More Information about "Barrier Therapeutics" on BioPortfolio

We have published hundreds of Barrier Therapeutics news stories on BioPortfolio along with dozens of Barrier Therapeutics Clinical Trials and PubMed Articles about Barrier Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Barrier Therapeutics Companies in our database. You can also find out about relevant Barrier Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record